TABLE 2.
SUMMARY OF INTERACTIONS BETWEEN RIFAMYCINS AND ANTIRETROVIRALS
| Rifampin | Rifabutin | |
|---|---|---|
| Cytochrome P450 interaction | +++ | + |
| Interactions with PIs | ++++, recommended for use only with a regimen that includes two PIs | ++, PIs boost Rif levels requiring reduction of dose |
| Interactions with NNRTIs | +, slightly decreases levels of efavirenz, but is favored regimen | ++, decreased levels of Rif with efavirenz requiring increased Rif dose. Should not be used with delaviridine |
| Interactions with CCR-5 receptor antagonists | + | + |
| Interactions with integrase inhibitors | + | + |
| Cost and availability | ++ | ++++, expensive and less available in resource-poor settings |
| Efficacy | ++++ | ++++ |
Definition of abbreviations: NNRTIs = nonnucleoside reverse transcription inhibitors; PIs = protease inhibitors; Rif = Rifabutin.